Exchange Traded Concepts, LLC

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-17
Total Holdings
1,875
Total Value
5805533727
Accession Number
0001213900-25-032764
Form Type
13F-HR
Manager Name
Exchange Traded Concepts, LLC
Data Enrichment
95% identified
1,773 identified102 unidentified

Holdings

1,875 positions
Manager:
Search and click to pin securities to the top
Page 57 of 63
Aon plc
Shares:
277(+121.6%)
Value:
$110.5M(+146.2%)
Fox Corp
Shares:
2097(-96.3%)
Value:
$110.5M(-95.7%)
Tyra Biosciences, Inc.
Shares:
11861(+42.7%)
Value:
$110.3M(-4.5%)
Arcus Biosciences, Inc.
Shares:
13922(+40.5%)
Value:
$109.3M(-25.9%)
Janux Therapeutics, Inc.
Shares:
4043(+20.4%)
Value:
$109.2M(-39.3%)
IDEAYA Biosciences, Inc.
Shares:
6659(+46.4%)
Value:
$109.1M(-6.7%)
Nurix Therapeutics, Inc.
Shares:
9145(+38.9%)
Value:
$108.6M(-12.4%)
Autolus Therapeutics plc
Shares:
69993(+67.2%)
Value:
$108.5M(+10.3%)
BICYCLE THERAPEUTICS PLC
Shares:
12764(+90.3%)
Value:
$108.4M(+15.4%)
HUNT J B TRANSPORT SERVICES INC
Shares:
731(+13.2%)
Value:
$108.2M(-1.9%)
DoorDash, Inc.
Shares:
591(-80.5%)
Value:
$108.0M(-78.7%)
NEWS CORP
Shares:
3964(-35.2%)
Value:
$107.9M(-35.9%)
Biomea Fusion, Inc.
Shares:
50550(+140.9%)
Value:
$107.7M(+32.2%)
Nuvation Bio Inc.
Shares:
60951(+11.7%)
Value:
$107.3M(-26.1%)
Zentalis Pharmaceuticals, Inc.
Shares:
67401(+48.1%)
Value:
$107.2M(-22.3%)
Cullinan Therapeutics, Inc.
Shares:
14107(+42.6%)
Value:
$106.8M(-11.3%)
PRECIGEN, INC.
Shares:
71566(-57.3%)
Value:
$106.6M(-43.1%)
Vor Biopharma Inc.
Shares:
148073(-10.7%)
Value:
$106.2M(-42.3%)
Schrodinger, Inc.
Shares:
5368(-36.3%)
Value:
$106.0M(-34.9%)
HUNTINGTON INGALLS INDUSTRIES, INC.
Shares:
518(-2.6%)
Value:
$105.7M(+5.1%)